| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/11/1992 | CA1295617C 1-¬(1,1-diphenyl)-1-alkenyl| pierazine derivatives, method of preparation and pharmaceutical compositions in which they are present |
| 02/11/1992 | CA1295615C 2-amino-3-aroyl- -oxobenzenebutanoic acids and esters |
| 02/09/1992 | WO1992002640A1 Cannabinoid receptor |
| 02/09/1992 | WO1992002488A1 Propylamine derivatives |
| 02/09/1992 | CA2088985A1 Propylamine derivatives |
| 02/09/1992 | CA2087844A1 Cannabinoid receptor |
| 02/09/1992 | CA2048315A1 Process for preparing enantiomers of compounds having muscarinic activity |
| 02/07/1992 | WO1992002502A1 N-hydrocarbyl-4-substituted piperidines, their preparation and use as calcium blocking agents |
| 02/07/1992 | WO1992002501A1 3-substituted piperidine derivatives |
| 02/07/1992 | CA2088491A1 N-hydrocarbyl-4-substituted piperidines, their preparation and use as calcium blocking agents |
| 02/07/1992 | CA2088490A1 3-substituted piperidine derivatives |
| 02/06/1992 | WO1992001670A1 Excitatory amino acid antagonists |
| 02/06/1992 | WO1992001460A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 02/06/1992 | WO1992001448A1 Remedy for sleep apnea |
| 02/06/1992 | CA2087160A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 02/05/1992 | EP0470039A2 Novel 3-arylindole and 3-arylindazole derivatives |
| 02/05/1992 | EP0469992A1 6-Alkylpyridazine derivatives, process for their preparation and compositions containing them |
| 02/05/1992 | EP0469984A2 N-sulfonyl-indoline derivatives, their preparation and pharmaceutical compositions containing them |
| 02/05/1992 | EP0469887A1 Acetamide derivatives |
| 02/05/1992 | EP0469450A1 p-Acylaminophenoxycarbamates and Derivatives |
| 02/05/1992 | CN1058405A 奎宁环衍生物 Quinuclidine derivatives |
| 02/05/1992 | CN1015365B Process for the preparation of 2-halonicergoline derivatives and their acid addition salts and new 2-halonicergolines |
| 02/04/1992 | WO1992002137A1 Neuroprotection by indolactam v and derivatives thereof |
| 02/04/1992 | US5086073 Brain disorders |
| 02/04/1992 | US5086072 Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| 02/04/1992 | US5086066 Method of providing anxiolytic and antipsychotic treatment with substituted benzamides |
| 02/04/1992 | US5086061 Use of beta blockers for the treatment of the progression of infantile axial myopia |
| 02/04/1992 | US5086058 Repetitive administration prior to drinking; opiate antagonist |
| 02/04/1992 | US5086054 Selective high-affinity ligands to sigma boding sites, administering, amipsychotic, antiarrhythmia, antiischemic agents anticonvulsants, reduced side effects |
| 02/04/1992 | US5086053 Derivatives of 1,3,4-thiadiazole, a method of obtaining them and pharmaceutical compositions containing them |
| 02/04/1992 | CA2088514A1 Neuroprotection by indolactam v and derivatives thereof |
| 02/04/1992 | CA1295341C Trienamide compounds having anti-inflammatory and analgesic activity |
| 02/04/1992 | CA1295333C Acylaminoalkanoyl compounds |
| 02/04/1992 | CA1295329C Fused imidazoheterocyclic compounds |
| 02/03/1992 | CA2048325A1 Acetamide derivatives |
| 02/01/1992 | WO1992002481A1 Arylcycloalkanepolyalkylamines |
| 02/01/1992 | CA2066593A1 Arylcycloalkanepolyalkylamines |
| 02/01/1992 | CA2048162A1 6-alkylpyridazine derivatives, method of preparation and pharmaceutical compositions in which they are present |
| 01/31/1992 | WO1992002487A1 New diamine compound and brain protecting agent containing the same |
| 01/31/1992 | CA2048099A1 P-acylaminophenoxycarbamates and derivatives |
| 01/31/1992 | CA2046576A1 Therapeutic agents |
| 01/29/1992 | EP0468875A2 Autoadhesive matrix system for transdermally controlled release of piribedil |
| 01/29/1992 | EP0468562A1 Tetrahydropyridinyl substituted tricyclic derivatives with dopamine antagonistic activity |
| 01/29/1992 | EP0468470A1 Benzimidazoles, medicaments containing them and process for their preparation |
| 01/29/1992 | EP0468401A2 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments |
| 01/29/1992 | EP0468187A2 Cyclic amide derivatives |
| 01/29/1992 | EP0324794B1 Oral administration capsule with a nicotine-containing fluid medium |
| 01/29/1992 | CN1058209A Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof |
| 01/29/1992 | CN1058207A Piperidine compound and its preparation |
| 01/28/1992 | US5084481 6,8-dimercaptooctanoic acid and salts for rheumatic diseases |
| 01/28/1992 | US5084479 Aminomethylcycloalkylacetic acids for nervous system disorders |
| 01/28/1992 | US5084474 Antagonist of 5-hydroxytryptamine receptors on nerves and useful for treatment of psychotic disorders, anxiety, and nausea and vomiting, compounds of imidazole |
| 01/28/1992 | US5084469 New substituted benzothiazolinones |
| 01/28/1992 | US5084456 Oxazolopyridine compounds |
| 01/28/1992 | US5084454 2-(piperidinylmethyl)-4-phenyl-2,3-dihydro-4h-1,4-benzoxazines useful as antipsychotics |
| 01/28/1992 | US5084452 2-azabicyclo(2,2,2)octane-3-carboxylic acid derivatives for the treatment of disorders of the cerebral circulation |
| 01/28/1992 | CA2041257A1 Cerebral function enhancing pyrimidinyl derivatives |
| 01/28/1992 | CA1294965C Amino-thiazole and oxazole derivatives |
| 01/28/1992 | CA1294964C Berban derivatives as a -adrenergic antagonists |
| 01/28/1992 | CA1294961C Aminoalcohols, their preparation process and their applications, particularly in therapeutics |
| 01/27/1992 | CA2087855A1 1,4-disubstituted piperazines |
| 01/25/1992 | WO1992001684A1 3-(1-substitutedpyrazoyl)-2-oxindole derivatives |
| 01/25/1992 | WO1992001449A1 Psychoactive drug and treatment |
| 01/25/1992 | CA2087546A1 Psychoactive drug and treatment |
| 01/25/1992 | CA2046488A1 Tetrahydropyridinyldibenzazepine derivatives |
| 01/24/1992 | WO1992001688A1 Quinuclidine derivatives |
| 01/24/1992 | CA2047508A1 Autoadhesive matrix system for sustained transdermal release of piribedil |
| 01/23/1992 | WO1992000737A1 Composition for the treatment of alzheimer's disease and process for preparing the same |
| 01/22/1992 | EP0467710A2 Method for treating Parkinson's disease employing the ATP-sensitive potassium channel blocker quinine |
| 01/22/1992 | EP0467709A2 Use of an ATP-sensitive potassium channel blocker to treat neuronal insult |
| 01/22/1992 | EP0467637A1 Pyrazolo(1,5-a)pyridine compounds, and production and use thereof |
| 01/22/1992 | EP0467614A1 Pyraxolidinone CCK and gastrin antogonists and pharmaceutical formulations thereof |
| 01/22/1992 | EP0467433A1 Use of a centrally acting ATCH analog in the manufacture of a medicament |
| 01/22/1992 | EP0467365A2 Use of a 5-hydroxytryptamine-3(5-HT3) receptor antagonist for the preparation of a pharmaceutical composition for treating urinary incontinence |
| 01/22/1992 | EP0467248A2 Pyrazolopyridine compound and processes for preparation thereof |
| 01/22/1992 | EP0467164A2 Flupirtine in combination with antiparkinsonica against muscle bracing |
| 01/22/1992 | EP0466769A1 Reducing post-prandial plasma large neutral amino acid concentrations. |
| 01/21/1992 | WO1992001690A1 Novel spiro-isoxazolidine derivatives as cholinergic agents |
| 01/21/1992 | US5082937 Benzodiazepines and applications in therapeutic practice |
| 01/21/1992 | US5082864 Stabilized solutions of psychotropic agents |
| 01/21/1992 | US5082858 Novel chroman derivatives active on the central nervous system, their method of preparation and pharmaceutical compositions in which they are present |
| 01/21/1992 | US5082843 Pyrazinyl and pyridazinyl ethers |
| 01/21/1992 | US5082842 Tricyclic pyridone derivatives |
| 01/21/1992 | CA2087529A1 Spiro-isoxazolidine derivatives as cholinergic agents |
| 01/21/1992 | CA2044855A1 Method for treating insult to neurons prone to parkinson's degeneration employing an atp-sensitive potassium channel blocker |
| 01/21/1992 | CA1294623C Decahydroquinolein derivatives, preparation process for same and new intermediates obtained, their application as medications and pharmaceuticals containing such |
| 01/21/1992 | CA1294619C Oleic acid esters and pharmaceutical compositions |
| 01/21/1992 | CA1294618C Pyridopyrimidinediones |
| 01/20/1992 | CA2044854A1 Method for preventing or treating urinary incontinence |
| 01/19/1992 | WO1992001672A1 Piperidine compounds, their preparation and use |
| 01/19/1992 | CA2087538A1 Piperidine compounds, their preparation and use |
| 01/19/1992 | CA2046999A1 Pyrazolo[1,5-a]pyridine compounds, and production and use thereof |
| 01/19/1992 | CA2045714A1 Use of a centrally acting acth analog in the manufacture of a medicament |
| 01/18/1992 | CA2046672A1 Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof |
| 01/15/1992 | EP0466585A1 Novel piperidin, tetrahydropyridine and pyrrolidine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/1992 | EP0466548A1 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indole and 1,2,3,4-tetrahydro-beta-carbolines, processes for their preparation, and pharmaceutical compositions containing them |
| 01/15/1992 | EP0465583A1 Use of a potassic agonist in the treatment of glaucoma |
| 01/14/1992 | US5081264 Bioxanthracene derivatives |
| 01/14/1992 | US5081137 Antidepressants |
| 01/14/1992 | US5081130 Derivatives of 1-arylsulphonyl-2-pyrrolidinone, their preparation process, intermediates thereof, their use as medicaments and compositions containing them |